Tim Ball

Tim has considerable experience in intellectual property dispute resolution. He has acted in over a quarter of all patent matters (and over three quarters of pharmaceutical patent matters) reported in Burrell’s Intellectual Property Law Reports since 2006 (as at 2013).

He has acted in matters before the High Court, the Court of the Commissioner of Patents, the Supreme Court of Appeal, and the Constitutional Court. These matters have included litigation on patents relating to medicines containing fexofenadine, amlodipine besylate, salmeterol/fluticasone propionate combinations, escitalopram, imatinib, emtricitabine (including in combinations with efavirenz and tenfovir), docetaxel, clopidogrel, and perindopril. These matters have also included litigation relating to copyright and trade marks.

Further, Tim has represented clients in proceedings before the complaints directorate of the Advertising Standards Authority, and the appellate tribunal established under the Medicines and Related Substances Control Act 101 of 1965. Tim previously practised as a director at DM Kisch, before moving to Cape Town to join Mallinicks in 2004. Tim joined Brian Bacon Inc. in 2006.

He is favourably mentioned in various rankings publications, including IAM Patent Litigation 250 (2011), IAM Patent 1000 (2012, 2013), Managing Intellectual Property (2013), Chambers & Partners (2013), and Legal 500 (2013).

  • Academic Qualifications

    B.Com, University of Port Elizabeth (now Nelson Mandela Metropolitan University), 1994
    LLB, University of Port Elizabeth (now Nelson Mandela Metropolitan University), 1996
    National Diploma: Engineering (mechanical), PE Technikon (now Nelson Mandela Metropolitan University), 1999

  • Admissions

    Attorney of the High Court of South Africa
    Patent Attorney (South Africa)

  • Professional Memberships

    Cape Law Society
    Fellow, South African Institute of Intellectual Property Law
    Licensing Executives’ Society